Copaifera (Copaifera langsdorffii)

Copaifera langsdorffii is an Amazonian tree whose oleoresin is rich in β-caryophyllene and kaurenoic acid, compounds that modulate inflammatory pathways and exhibit antioxidant activity. Most documented effects derive from preclinical models, with human clinical evidence remaining sparse.

Origin & History

Copaifera langsdorffii is a tree species native to Brazil, belonging to the Fabaceae family. Copaiba oleoresin, rich in diterpenes, sesquiterpenes, and flavonoids, is extracted from the tree's trunk and leaves using methods like supercritical fluid extraction and maceration.

Historical & Cultural Context

Copaifera langsdorffii has a history of use in Brazilian traditional medicine for its oleoresin, which is valued for its therapeutic effects against various ailments. The resins, composed of volatile sesquiterpene oils, have been used empirically in traditional practices.

Health Benefits

• Antioxidant properties due to high flavonoid content, though evidence is limited to preclinical studies. • Potential anti-inflammatory effects suggested by kaurenoic acid in preclinical models. • High β-caryophyllene content may confer some therapeutic benefits, but human studies are absent. • Phenolic compounds in extracts show promise in free radical scavenging in vitro. • Leaf extracts with high kaurenoic acid levels exhibit biological effects in animal models.

How It Works

β-Caryophyllene, a primary sesquiterpene in Copaifera oleoresin, acts as a selective agonist of the CB2 cannabinoid receptor, suppressing NF-κB signaling and reducing pro-inflammatory cytokine release including TNF-α and IL-6. Kaurenoic acid, a diterpene constituent, inhibits cyclooxygenase (COX) enzymes and may interfere with the arachidonic acid cascade to attenuate prostaglandin synthesis. Flavonoids present in leaf and bark extracts scavenge reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, contributing to the observed antioxidant capacity in DPPH and ABTS assays.

Scientific Research

No human clinical trials or meta-analyses specific to Copaifera langsdorffii are available. Current evidence is limited to in-vitro and animal studies focusing on its phytochemical properties and biological effects.

Clinical Summary

The overwhelming majority of evidence for Copaifera langsdorffii comes from in vitro cell studies and rodent models, where oleoresin doses of 100–400 mg/kg demonstrated anti-inflammatory and antimicrobial effects. A small number of pilot studies in humans have examined topical or oral application of copaiba oil, but these trials typically involve fewer than 50 participants, lack placebo controls, and report primarily subjective outcomes. One limited randomized trial suggested modest reduction in oral inflammation markers with topical copaiba gel, yet effect sizes were small and follow-up periods short. No large-scale, double-blind, placebo-controlled trials currently support definitive therapeutic claims for any indication in humans.

Nutritional Profile

Copaifera langsdorffii is not consumed as a conventional food, so standard macronutrient profiling (protein, carbohydrates, fat, fiber) is not typically applicable. Its value lies in its oleoresin and leaf/bark extracts rich in bioactive compounds. Key constituents include: **Oleoresin (copaiba oil):** Composed primarily of sesquiterpenes and diterpenes. β-Caryophyllene is the dominant sesquiterpene, often comprising 40–57% of the volatile fraction; it acts as a selective CB2 cannabinoid receptor agonist. Other sesquiterpenes include α-humulene (~5–10%), α-copaene (~3–8%), and β-elemene (~2–5%). Diterpene acids include kaurenoic acid (ent-kaur-16-en-19-oic acid, ~3–15% of the resinous fraction), copalic acid (~5–12%), and hardwickiic acid (~2–8%). **Leaf extracts:** Rich in phenolic compounds including gallic acid (~1.5–4.0 mg/g dry weight), quercetin and quercetin glycosides (~0.8–2.5 mg/g dry weight), kaempferol derivatives, and other flavonoids contributing to total flavonoid content of approximately 8–20 mg quercetin equivalents/g dry extract. Total phenolic content of leaf extracts ranges from approximately 50–150 mg gallic acid equivalents (GAE)/g dry extract depending on solvent and extraction method. **Minerals (in leaf tissue, approximate):** Calcium (~8–15 mg/g), potassium (~10–18 mg/g), magnesium (~2–5 mg/g), iron (~0.05–0.2 mg/g), and zinc (~0.02–0.06 mg/g dry weight), though these values vary with soil and growing conditions. **Bioavailability notes:** β-Caryophyllene is lipophilic and has moderate oral bioavailability, enhanced when consumed with dietary fats or as part of the oleoresin matrix. Kaurenoic acid and other diterpene acids are poorly water-soluble, and their oral bioavailability in humans is not well characterized. Flavonoid glycosides from leaf extracts require intestinal hydrolysis for aglycone absorption; quercetin bioavailability is generally low (~2–5%) but may be improved by the presence of other phenolics and lipid co-administration. No standardized nutritional reference values exist for copaiba products as they are classified as traditional remedies rather than foods.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Preclinical studies use varying extraction methods without standardized dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Boswellia, Black Pepper, Green Tea

Safety & Interactions

Oral ingestion of Copaifera oleoresin in high doses has been associated with gastrointestinal disturbances including nausea, vomiting, diarrhea, and abdominal cramping, particularly at doses exceeding 1–2 mL of raw oleoresin. Topical use is generally better tolerated but contact dermatitis has been reported in sensitized individuals. Because β-caryophyllene activates CB2 receptors, theoretical interactions exist with immunosuppressive drugs and cannabinoid-modulating medications, though direct pharmacokinetic interaction data in humans are unavailable. Use during pregnancy and lactation is not recommended due to the absence of safety data and historical use as an abortifacient in traditional Amazonian medicine.